Document Server@UHasselt >
Research >
Research publications >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/21284

Title: Attenuated atrial natriuretic peptide-mediated lipolysis in subcutaneous adipocytes of obese type 2 diabetic men
Authors: Verboven, Kenneth
Hansen, Dominique
Moro, Cedric
Op 't Eijnde, Bert
Hoebers, N.
Knol, J.
Bouckaert, W.
Dams, A.
Blaak, E.E.
Jocken, J.W.E.
Issue Date: 2016
Citation: CLINICAL SCIENCE, 130 (13), p. 1105-1114
Abstract: Aims/hypothesis Catecholamines and atrial natriuretic peptide (ANP) are major regulators of adipocyte lipolysis. Although obesity is characterized by catecholamine resistance in subcutaneous adipose tissue (SCAT), data on ANP lipolytic response and sensitivity in different adipose tissue depots of metabolically distinct humans are scarce.Methods Ex vivo catecholamine- and ANP-induced lipolysis was investigated in adipocytes derived from SCAT and visceral (VAT) depot of lean (n=13) and obese men, with (n=11) or without (n=18) type 2 diabetes (HbA1c < or ≥6.5%). Underlying molecular mechanisms were examined by looking at functional receptors in the NP signaling pathway on mRNA and protein level.Results Maximal ANP- and catecholamine-induced lipolysis in SCAT was blunted in obese type 2 diabetic compared with age-matched lean men whilst non-diabetic obese subjects showed intermediate responses. This blunted ANP-mediated lipolytic response was accompanied by lower mRNA and protein expression of the type-A natriuretic peptide (NP) receptor and higher mRNA but reduced protein expression of the scavenging type-C receptor. Maximal ANP-induced lipolysis was lower in VAT compared to SCAT but not different between groups.Conclusions/interpretation Collectively, our data show that both ANP- and catecholamine-mediated lipolysis is attenuated in SCAT of obese men with type 2 diabetes, and might be partially explained by NP receptor defects. Therefore, improving maximal ANP responsiveness in adipose tissue might be a potential novel strategy to improve obesity-associated metabolic complications.
Notes: Verboven, K (reprint author), Maastricht Univ, Med Ctr, NUTRIM Sch Nutr & Translat Res Metab, NL-6200 MD Maastricht, Netherlands. k.verboven@maastrichtuniversity.nl
URI: http://hdl.handle.net/1942/21284
DOI: 10.1042/CS20160220
ISI #: 000393760200006
ISSN: 0143-5221
Category: A1
Type: Journal Contribution
Appears in Collections: Research publications

Files in This Item:

Description SizeFormat
published version292.11 kBAdobe PDF

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.